25 results
Drugs for Heart Failure

#medications #chf #pathophysiology #cardiology #pharmacology
#medications #chf ... #pathophysiology ... #cardiology #pharmacology
Pharmacology of diuretics

Acetazolamide, Loop diuretics, Thiazide‐like diuretics, MRA, Amiloride

Site of Action, Maximum Dose, Half-Life, Onset, Bioavailability,
Pharmacology of ... #Diuretics #Pharmacology ... #Comparison #Table ... Loop #Thiazide #CHF ... #Cardiology #Management
Congestive Heart Failure - Causes, Pathophysiology and Differential Diagnosis
 • Dilated Cardiomyopathy 
 • Hypertrophic Cardiomyopathy
Failure - Causes, Pathophysiology ... Afterload • Valvular ... HeartFailure #Causes #Pathophysiology ... Differential #Diagnosis #cardiology ... #HFrEF #HFpEF #CHF
Causes of Hemoptysis - Differential Diagnosis Algorithm
Massive Hemoptysis (>I00 mL in 24 hours)
 • Malignancy
 •
Differential Diagnosis Algorithm ... Malformation Normal CXR ... Abnormalities • CHF ... polyangiitis Vascular ... Differential #Diagnosis #Algorithm
CHF - Left-Sided Heart Failure - Differential Diagnosis Algorithm

Valvular Disease (Preserved Diastolic/Systolic Function)
 • Mitral Stenosis
CHF - Left-Sided ... Differential Diagnosis Algorithm ... Valvular Disease ... Constriction #CHF ... #HeartFailure #Cardiology
Iron Deficiency in Congestive Heart Failure (CHF)

Iron deficiency (ID) in heart failure is a common comorbidity
Heart Failure (CHF ... Heart #Failure #CHF ... #pharmacology # ... pathophysiology ... #cardiology
Stage I - Redistribution
In a normal chest film with the patient standing erect, the pulmonary vessels
The pulmonary vascular ... In these cases comparison ... during a period of CHF ... #Clinical #Radiology ... #CXR #CHF #Cephalization
Shock and Vasoactive Drugs 
1) Determine type and etiology of shock
 • Distributive: Sepsis, Anaphylaxis, Neurogenic
Heart Failure, Valvular ... Arrhythmias / CHB ... vasoactive drug pharmacology ... Vasoactive #Drugs #pharmacology ... diagnosis #management #comparison
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
blood donor • Pathophysiology ... : Age>60, CKD, CHF ... transfusion • Pathophysiology ... fluid balance, and CXR ... hematology #diagnosis #comparison
Heart failure with Reduced Ejection Fraction (HFrEF)
Clinical Presentation
1. Typical symptoms: dyspnea, orthopnea paroxysmal noctumal dyspnea, fatigue,
0.25), murmur of valvular ... → no signs of CXR ... endomyocardial biopsy Pharmacology ... diagnosis #management #cardiology ... #pharmacology #